MAC_LOGO_Transparent_background    EP_Logo_Transparent


NEWS: READ the article from the Parliament Magazine on "MEPs Unite in the Fight Against Cancer", Jan 2015



MAC organised a rountable on the 4th Revision of the European Code Against Cancer in December 2014 


The MEPs Against Cancer (MAC) group was renewed by key cancer control MEPs at its first roundtable of the eighth legislature at the European Parliament on 10 September!



Peterle 002


Returning MEP champions for the launching of the MEPs Against Cancer (MAC) of the Eighth Legislature:

Mr Miroslav Mikolášik, Mr Charles Tannock, Mrs Glenis Willmott, Mr Alojz Peterle, Mr Pavel Poc.


 "I think it is crucial for this term to provide more added value in the fight against cancer at the EU level, as well as better co-operation with stakeholders in the Member States. What is of the utmost importance is a concrete preventive policy in order to diminish the inflow of new cancer patients, which has been also the wish of the cancer patients in the EU."

- Mr Alojz Peterle, MAC President


The MEPs Against Cancer (MAC) group is an informal group of Members of the European Parliament (MEPs) at the European Parliament committed to actions against cancer.





Past news:




Selected statements in support of the MAC Election Manifesto:


Alojz Peterle, MEP and MAC President

Alojz Peterle MAC President EPP

We politicians are privileged in being able to support EU citizens and patients, in particular in their fight against cancer. But it needs political will. We MEPs can help build that political will. Please join us in our fight against cancer.


Pavel Poc, MEP and MAC Ambassador for Colorectal Cancer

Pavel Poc MEP photo

Every year, more than 150 000 EU citizens die because of colorectal cancer. That is about one Titanic catastrophe every three days. But many of these deaths could be prevented as we have convincing evidence that screening for colorectal cancer is highly effective. We need to do more in addressing inequalities between and within Member States when fighting colorectal and other types of cancer. Additionaly, effective screening programmes can also economicaly help our healthcare systems.


Linda McAvan, MEP

Linda McAvan 2

I am pleased to support the MEPs Against Cancer manifesto, which calls for a range of important initiatives to improve cancer prevention in the coming years. I have recently focused my efforts on tobacco control, and have appreciated the support and cooperation of the MEPs Against Cancer group in this regard. The new EU law we have chieved will reduce the number of young people starting to smoke, and help tackle this terrible and preventable cause of cancer. More broadly I endorse the message of MEPs Against Cancer that European cooperation can enhance national initiatives so that we can fight all forms of cancer together.  


Ivo Belet, MEP


Cancer is one of Europe's biggest killers. We should fully exploit the huge benefits of scale which lie in research coordination at European level and cross-border cooperation in treatment, especially of rare cancers. We need a full fledged European Cancer Strategy to achieve the 15% incidence reduction target in 2020.


Pat the Cope Gallagher, MEP

Pat the Cope Gallagher

I fully support the EU's goal to reduce cancer rates across Europe by 15% by the year 2020. Such targets are a necessary incentive to reduce the prevalence of preventable forms of cancer. I am in favour of increasing EU investment in this area in order to reach the 2020 targets and to ensure that fewer Europeans suffer from cancer in future generations.


Bart Staes, MEP

Bart Staes 

Ik steun van harte dit verkiezingsmanifest en bij herkiezing zal ik verder blijven voor ijveren dat het ook wordt uitgevoerd. (I wholeheartedly support this Manifesto and to re-election. I will continue the work to ensure that it is implemented.)


MAC is an all-party informal group of Members of the European Parliament  (MEPs) committed to promoting action on cancer as an EU priority and harnessing European health policy to that end.

Through quarterly roundtable discussions between  MEPs, other policy makers and invited guests, the group aims to strengthen the political will needed to fight cancer in Europe.

The MAC Secretariat is provided by ECL.


The Facts Speak for Themselves

Cancer is not one disease but over 200 different  types of disease, ranging from the well-known big cancer killers to rarer conditions such as multiple myeloma and chronic myeloid leukaemia. One in three Europeans is diagnosed with cancer, and the disease kills one in four people.

The burden of cancer in Europe continues to increase. The strain is tremendous and immeasurable on patients, families, and societies.

In 2012, there was an estimated 3.4 million new cases (excluding non-melanoma skin), and 1.8 million cancer deaths in Europe. Both genders were affected almost equally: of the 3,439,598 new cancer cases diagnosed in 2012, 53.2% were among men and 46.8% among women. There were 1,754,550 cancer deaths, of which 55.9% were in men and 44.1% in women. The biggest killers of the 1.8 million deaths in 2012 were lung, colorectal, breast, and stomach cancers.

Results from the EUROCARE-5 study launched at a MAC roundtable show that the number of adults surviving for at least 5 years after diagnosis has risen steadily over time in all European regions  from 1999 to 2007, but cancer survival still varies widely between European countries.  Countries with lowest survival for most cancers (Bulgaria, Estonia, Latvia, Lithuania, Poland, and Slovakia) are in Eastern Europe. Here, survival is below the European mean, particularly for good prognosis cancers like colon, rectum, lymphomas, and skin melanoma.  

Nordic countries (with the exception of Denmark), central European countries such as Austria, Belgium, France, Germany, Switzerland, and Netherlands, and some countries in southern Europe (Italy, Portugal, and Spain), have the best survival for most cancers. Childhood cancer remains a public health issue. Survival at 5 years from diagnosis for children (0-14 years) for all cancers combined is generally good, with 79% now surviving (2005–2007), up from 76% in 1999–2001. However, no progress has been achieved for paediatric malignancies with the poorest prognosis.


MEPs and national politicians can join to help us end unnecessary death and suffering from cancer!

Translate (done by a generic software and translations will be flawed)

English French German Italian Portuguese Russian Spanish


logo_EWAC_transparent_background_w_DATES     cancon logo horizontal RGB SMALL    rarecancers_logo_tagline_rgb_72dpi


The text of this webpage is available for modification and reuse under the terms of the Creative Commons Attribution-Sharealike 3.0 Unported License and the GNU Free Documentation License (unversioned, with no invariant sections, front-cover texts, or back-cover texts).



Slideshow MEP

Go to top